Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;142(1):27-38.
doi: 10.1007/s11060-018-03073-z. Epub 2018 Dec 12.

Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival

Quinn T Ostrom  1   2 , Haley Gittleman  1   3 , Carol Kruchko  1 , Jill S Barnholtz-Sloan  4   5
Affiliations

Primary brain and other central nervous system tumors in Appalachia: regional differences in incidence, mortality, and survival

Quinn T Ostrom et al. J Neurooncol. 2019 Mar.

Abstract

Background: The Appalachian region is a large geographic and economic area, representing 7.69% of the United States (US). This region is more rural, whiter, older, and has a higher level of poverty as compared to the rest of the US. Limited research has been done on primary brain and other central nervous system tumors (PBT) epidemiology in this region. In this analysis we characterize incidence, mortality, and survival patterns.

Methods: Data from 2006 to 2015 were obtained from the central brain tumor registry of the US (provided by CDC and NCI). Appalachian counties were categorized using the Appalachia Regional Council scheme. Overall and histology-specific age-adjusted incidence and mortality rates per 100,000 population were generated. 1-, 5-, and 10-year relative survival (RS) was estimated using CDC national program of cancer registry data from 2001 to 2014.

Results: Overall PBT incidence within Appalachia was 22.62 per 100,000, which is not significantly different from the non-Appalachian US (22.77/100,000, p = 0.1189). Malignant incidence was 5% higher in Appalachia (7.55/100,000 vs. 7.23/100,000, p < 0.0001), while non-malignant incidence was 3% lower (15.07/100,000 vs. 15.54/100,000, p < 0.0001). 5-year RS for malignant PBT was lower (31.4% vs. 36.0%), and mortality due to malignant PBT was higher in Appalachia (4.86/100,000 vs. 4.34/100,000, p < 0.0001).

Conclusion: Appalachia has increased malignant and decreased non-malignant PBT incidence, and poorer survival outcomes for malignant PBT compared to the non-Appalachian US.

Keywords: Appalachia; Brain and CNS tumors; Incidence; Mortality; Relative survival.

PubMed Disclaimer

References

    1. Cancer. 2004 Aug 1;101(3):613-9 - PubMed
    1. J Rural Health. 2005 Winter;21(1):39-47 - PubMed
    1. J Rural Health. 2005 Summer;21(3):245-53 - PubMed
    1. Biometrics. 2006 Sep;62(3):847-54 - PubMed
    1. J Ky Med Assoc. 2008 Oct;106(10):489-93 - PubMed

MeSH terms